Publications by authors named "Seng G Lim"

Claim this Profile
E
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, Scott Fung, Mang M Ma, Shalimar, Seng Gee Lim, Young-Suk Lim

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study.
Jie Li, Joanne Kimiko Liu, Angela Chau, Sovann Linden, Pei-Chien Tsai, Seng Gee Lim

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for a globally unified chronic HBV terminology?
Su Wang, Catherine Freeland, Seng Gee Lim, Hailemichael Desalegn, Chari Cohen

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).
Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, Marc Bourliere, Shaowen Jiang, Fabien Zoulim

Gut· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential HCC risk among HBV indeterminate types at baseline and by phase transition.
Rui Huang, Huy N Trinh, Satoshi Yasuda, Angela Chau, Mayumi Maeda, Seng Gee Lim

Gut· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines.
Patrick T Kennedy, Lena Allweiss, Antonio Bertoletti, Markus Cornberg, Adam J Gehring, Seng Gee Lim

Lancet Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.
Angela Chau, Jie Li, Dae Won Jun, Yao-Chun Hsu, Hidenori Toyoda, Seng Gee Lim

J Viral Hepat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.
Rui Huang, Ai-Thien Do, Hidenori Toyoda, Jie Li, Satoshi Yasuda, Seng Gee Lim

Aliment Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardising HBV nomenclature: a call to action from the HBV Forum.
Su Wang, Mitchell Leus, Markus Cornberg, Marc Ghany, Carey Hwang, Seng Gee Lim

Lancet Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis.
Nobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Tae Seop Lim, Seng Gee Lim

J Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.
Ashok Choudhury, Anand V Kulkarni, Vinod Arora, A S Soin, Abdul Kadir Dokmeci, Seng Gee Lim, Shalimar

Hepatol Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-Regression.
Seng Gee Lim, Ada Ee Der Teo, Edwin Shih-Yen Chan, Wah Wah Phyo, David Hsing Yu Chen

Clin Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing reveals anti-tumor potency of CD56 NK cells and CD8 T cells in humanized mice via PD-1 and TIGIT co-targeting.
Wai Nam Liu, Sarah L Harden, Shawn Lu Wen Tan, Rachel Jun Rou Tan, Shin Yie Fong, Seng Gee Lim

Mol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies.
Mark Anderson, Vera Holzmayer, Michael Stec, Gavin Cloherty, Seng Gee Lim

J Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity.
Balakrishnan Chakrapani Narmada, Atefeh Khakpoor, Niranjan Shirgaonkar, Sriram Narayanan, Pauline Poh Kim Aw, Seng Gee Lim

J Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon.
Daniel Q Huang, Liang Shen, Wah Wah Phyo, Gavin Cloherty, Emily K Butler, Seng Gee Lim

Antiviral Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world.
Sahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, Lindsey Trinh, P C Tsai, Seng Gee Lim

J Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.
Fanpu Ji, Sally Tran, Eiichi Ogawa, Chung-Feng Huang, Takanori Suzuki, Seng Gee Lim

J Clin Transl Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients.
Jinlin Hou, Edward Gane, Rozalina Balabanska, Wenhong Zhang, Jiming Zhang, Tien Huey Lim, Seng Gee Lim

Clin Mol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q Huang, Sung Eun Kim, Seng Gee Lim

Clin Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B: Better But Not Enough.
Seng Gee Lim, Yong Chuan Tan

Gastroenterology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females.
Darren Tan, Kai En Chan, Zhen Yu Wong, Cheng Han Ng, Jieling Xiao, Wen Hui Lim, Seng Gee Lim

Dig Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO 2030 HBV elimination goals: a goal too far?
Seng Gee Lim

Lancet Gastroenterol Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Young-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, Wai Kay Seto, Qin Ning, Shalimar, Seng Gee Lim

JHEP Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Improved basic performance of iTACT-HBcrAg assay" and "Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations".
Seng Gee Lim, Ee Jin Yeo, Celina Adraneda, Yong Chuan Tan

J Hepatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis